Want to see ALXO full AI Analyst Report?
ALX Oncology Holdings (ALXO) Ownership Overview
9.79% Insiders
3.49% Mutual Funds
51.73% Other Institutional Investors
7.57% ETFs
27.43% Public Companies and
Individual Investors
The ownership structure of ALX Oncology Holdings (ALXO) stock is a mix of institutional, retail, and individual investors. Approximately 62.78% of the company’s stock is owned by Institutional Investors, 9.79% is owned by Insiders, and 27.43% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 18, 2026 | xxxxxxxxxxxxx | $1106 | |
Mar 23, 2026 | xxxxxxxxxxxxx | $26715 | |
Mar 23, 2026 | xxxxxxxxxxxxx | $1960 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $1283 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $154879 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $12472247 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $13648634 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,052,008 | Insider | 9.44% | 19,186,452 | |
| 13,011,849 | Institution | 9.41% | 19,127,418 | |
| 6,593,543 | Institution | 4.77% | 9,692,508 | |
| 6,025,240 | Institution | 4.36% | 8,857,103 | |
| 5,616,775 | Institution | 4.06% | 8,256,659 | |
| 4,043,573 | Institution | 2.92% | 5,944,052 | |
| 3,832,041 | Institution | 2.77% | 5,633,100 | |
| 343,297 | Institution | 0.25% | 504,647 | |
| 294,379 | Insider | 0.21% | 432,737 | |
| 208,172 | Institution | 0.15% | 306,013 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,043,573 | Institution | 2.92% | 5,944,052 | |
| 343,297 | Institution | 0.25% | 504,647 | |
| 98,277 | Institution | 0.07% | 144,467 | |
| 92,753 | Institution | 0.07% | 136,347 | |
| 76,072 | Institution | 0.06% | 111,826 | |
| 72,511 | Institution | 0.05% | 106,591 | |
| 63,652 | Institution | 0.05% | 93,568 | |
| 13,700 | Institution | <0.01% | 20,139 | |
| 11,919 | Institution | <0.01% | 17,521 | |
| 1,962 | Institution | <0.01% | 2,884 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,642,854 | Institution | 2.63% | 7,030,708 | |
| 2,564,908 | Institution | 1.85% | 3,475,450 | |
| 1,226,065 | Institution | 0.89% | 2,366,305 | |
| 922,553 | Institution | 0.67% | 1,250,059 | |
| 621,552 | Institution | 0.45% | 1,199,595 | |
| 319,670 | Institution | 0.23% | 433,153 | |
| 208,172 | Institution | 0.15% | 306,013 | |
| 187,690 | Institution | 0.14% | 254,320 | |
| 122,122 | Institution | 0.09% | 179,519 | |
| 117,143 | Institution | 0.08% | 226,086 |
FAQ
Who Owns ALX Oncology Holdings (ALXO)?
According to the latest TipRanks data, approximately 51.73% of the company's stock is held by institutional investors, 9.79% is held by insiders, and 27.43% is held by retail investors.
What percentage of ALX Oncology Holdings (ALXO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.73% of ALX Oncology Holdings (ALXO) stock is held by institutional investors.
What percentage of ALX Oncology Holdings (ALXO) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.43% of ALX Oncology Holdings (ALXO) stock is held by retail investors.
Who owns the most shares of ALX Oncology Holdings (ALXO)?
Corey Goodman owns the most shares of ALX Oncology Holdings (ALXO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.